New Technologies To Reduce The Population Burden Of Sexually Transmitted Infections
Funder
National Health and Medical Research Council
Funding Amount
$772,605.00
Summary
I propose a five year program of public health research on the evaluation of innovative technologies to prevent sexually transmitted infections (STIs) and their adverse consequences in populations at highest risk; Aboriginal and Torres Strait Islander people, youth, men who have sex with men and people in high STI-burden resource-limited countries. My research over the next five years will lead to substantial improvements in the health of people at greatest risk of STIs.
Evaluating The Uptake And Impact Of The HIV/STI Prevention And Treatment Revolution
Funder
National Health and Medical Research Council
Funding Amount
$435,411.00
Summary
The aims of this ECF are to: a) assess the uptake and impact of new HIV prevention options; b) evaluate the effectiveness of antibiotic treatment for bacterial STIs; and c) determine risk factors of ill health caused by STIs. State-of-the-art methods will be applied for the design and analysis of various types of studies. All research will inform HIV/STI policy, prevention programs, and clinical practice – in Australia and abroad. Findings will be disseminated widely e.g. to policy makers.
Rapid Point-of-Care (POC) Tests For Sexually Transmitted Infections (STIs): Evaluation Of Accuracy, Acceptability And Impact In Australia And Papua New Guinea (PNG)
Funder
National Health and Medical Research Council
Funding Amount
$99,883.00
Summary
This research, composed of three studies, aims to evaluate rapid point-of-care tests for selected sexually transmitted infections (including syphilis, Chlamydia and gonorrhoea) to determine their accuracy and acceptability, their potential role in and impact on control of STIs in Papua New Guinea and remote settings in Australia.
Viral Load, HIV Treatment, And HIV Transmission In Serodiscordant Male Homosexual Couples
Funder
National Health and Medical Research Council
Funding Amount
$1,452,298.00
Summary
HIV treatment reduces the concentration of HIV in the body. In heterosexuals, current studies will determine the effectiveness of HIV treatment in preventing onwards HIV transmission. In contrast, there has been very little such research in homosexual men, who comprise 70% or more of people with HIV in Australia. This study will follow for four years over 200 male homosexual couples in which one is HIV positive and the other negative, to investigate the role of HIV treatment in HIV prevention.
The Second Australian Study Of Health And Relationships
Funder
National Health and Medical Research Council
Funding Amount
$1,637,477.00
Summary
The present proposal is for the Second Australian Study of Health and Relationships, a survey of 20,000 Australians aged 16–69, in 2011–12 in order to understand and document the changes in Australian sexual behaviour over the past decade. It is essential that policy and practice in the arena of sexual and reproductive health be evidence-based and that the evidence base be as current as is practicable.
Treatment Of Rectal Chlamydia Infection In Gay And Bisexual Men
Funder
National Health and Medical Research Council
Funding Amount
$64,713.00
Summary
Rectal chlamydia is very common in gay men; it can exist for long periods without symptoms leading to ongoing transmission. There are two choices for antibiotic treatment: azithromycin and doxycycline, but there is uncertainty about which is more effective. This research will determine which treatment is best and what the economic implications are. The findings will update treatment guidelines and ensure that the most effective treatment is used to prevent ongoing transmission.
Investigation Of Candidate Aetiologic Organisms Of Bacterial Vaginosis In Diverse And Unique Epidemiological And Clinical Studies
Funder
National Health and Medical Research Council
Funding Amount
$564,438.00
Summary
Bacterial vaginosis (BV), a vaginal infection affecting 10% of Australian women, is an important cause of premature birth, yet its cause is unknown. We are conducting studies to understand the cause of BV in order to improve diagnosis and treatment.
Reducing The Impact Of Blood Borne Viruses And Sexually Transmitted Infections In Young People.
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
Over the next five years I will undertake a program of research centred on reducing the impact of blood-borne viruses and sexually transmitted infections in vulnerable populations, particularly focusing on HCV and HIV elimination. I will use innovative systems and methods to study how these infections are transmitted and develop interventions that reduce disease transmission and associated risk-behaviours (drug and alcohol use and sexual behaviours) and increased testing and treatment.
Behavioural And Microbial Risk Factors Associated With Bacterial Vaginosis In Young Women
Funder
National Health and Medical Research Council
Funding Amount
$290,032.00
Summary
Bacterial vaginosis (BV) is one of the commonest genital infections in women of reproductive age. Few data have determined the incidence of BV among young low risk women and the associated risk factors. This study aims to establish the incidence of BV in a cohort of young women and determine if BV is sexually transmitted. We hope this research will led to improvements in management and treatment of BV.
The Development And Evaluation Of Public Health Strategies For Preventing Infectious Diseases In Populations At Risk
Funder
National Health and Medical Research Council
Funding Amount
$863,413.00
Summary
The research program proposed in this application will focus on strategies for reducing the impact of infectious diseases in populations most at risk. It will provide new knowledge that will lead to direct public health outcomes, including large reductions in curable sexually transmitted infections in remote Aboriginal communities, comprehensive assessments of the effectiveness of national immunisation programs against important infections and lowered HIV transmission in Asia-Pacific countries.